(+)-Posiphen Uses, Dosage, Side Effects and more

(+)-Posiphen is under investigation in clinical trial NCT02925650 (Safety, Tolerability, PK and PD of (+)-Posiphen® in Subjects With Early Alzheimer's Disease).

Attribute	Details
Trade Name	(+)-Posiphen
Generic	Posiphen
Posiphen Other Names	(+)-Posiphen
Type
Formula	C20H23N3O2
Weight	Average: 337.423 Monoisotopic: 337.179026993
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph